{"id":87,"date":"2024-11-14T16:44:21","date_gmt":"2024-11-14T16:44:21","guid":{"rendered":"https:\/\/myosotisinvestments.com\/?page_id=87"},"modified":"2026-04-17T10:53:12","modified_gmt":"2026-04-17T10:53:12","slug":"portfolio","status":"publish","type":"page","link":"https:\/\/myosotisinvestments.com\/index.php\/portfolio\/","title":{"rendered":"Portfolio"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Mission&#8221; _builder_version=&#8221;4.27.4&#8243; background_color=&#8221;gcid-heading-color&#8221; background_image=&#8221;https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2024\/11\/Myosotis-background.png&#8221; custom_padding=&#8221;||31px|||&#8221; animation_direction=&#8221;bottom&#8221; border_color_all=&#8221;gcid-secondary-color&#8221; box_shadow_style=&#8221;preset6&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;7px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-heading-color%22:%91%22background_color%22%93,%22gcid-secondary-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_row _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;19px&#8221; header_font_size=&#8221;82px&#8221; text_text_shadow_style=&#8221;preset2&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_font=&#8221;&#8211;et_global_heading_font||||||||&#8221; text_text_color=&#8221;#FFFFFF&#8221; text_font_size=&#8221;70px&#8221; header_font_size=&#8221;82px&#8221; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||-10px||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Portfolio<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Logos&#8221; _builder_version=&#8221;4.27.3&#8243; z_index=&#8221;1&#8243; custom_margin=&#8221;-12px||-2px||false|false&#8221; custom_padding=&#8221;||0px|||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;rgba(70,99,175,0.11)&#8221; background_image=&#8221;https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2024\/06\/venture_03.png&#8221; custom_margin=&#8221;-33px|||||&#8221; custom_padding=&#8221;43px||57px|||&#8221; animation_style=&#8221;fade&#8221; animation_direction=&#8221;bottom&#8221; border_color_all=&#8221;gcid-secondary-color&#8221; box_shadow_style=&#8221;preset1&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-secondary-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663af&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; animation_style=&#8221;fade&#8221; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2024\/11\/idevax_logo_black_20220921-300x180.png\" width=\"228\" height=\"137\" alt=\"\" class=\"wp-image-98 alignnone size-medium\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;IDEVAX B.V.&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/idevax.com\/&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p>Antwerpen, Belgium<\/p>\n<p><span><\/span><\/p>\n<p>An innovative developer and producer of medical devices offering accurate and reliable intradermal drug delivery devices.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663AF&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; animation_style=&#8221;fade&#8221; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2026\/02\/KBL-LOGO-with-Name-White-Background-1-300x219.jpg\" width=\"247\" height=\"180\" alt=\"\" class=\"wp-image-348 alignnone size-medium\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;Kairos Biotech Ltd.&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/kairosbiotech.com\/&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><span>\u00a0Denbighshire<\/span>, United Kingdom<\/p>\n<p><span><\/span><\/p>\n<p><span class=\"lt-line-clamp__line\">Research and development of transplant diagnostics and immunotherapy solutions targeting<\/span><span>\u00a0<\/span><span class=\"lt-line-clamp__line lt-line-clamp__line--last\">transplantation tolerance.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.27.3&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663AF&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; custom_margin=&#8221;6px|||||&#8221; animation_style=&#8221;fade&#8221; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2025\/02\/TZU_logo_Liggend_RGB-1-300x94.png\" width=\"316\" height=\"99\" alt=\"\" class=\"wp-image-241 alignnone size-medium\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;Tzu Cancer Therapeutics B.V.&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/tzu.nl\/&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><span>\u00a0Amsterdam<\/span>, The Netherlands<\/p>\n<p><span><\/span><\/p>\n<p><span>To develop personalized therapies based on the molecular analysis of Circulating Tumor Cells.<\/span><\/p>\n<p><span><\/span><\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_3,1_3,1_3&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_3&#8243; disabled_on=&#8221;off|off|off&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663af&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; animation_style=&#8221;fade&#8221; hover_enabled=&#8221;0&#8243; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2026\/01\/Cyclomics-300x84.png\" width=\"314\" height=\"88\" alt=\"\" class=\"wp-image-337 alignnone size-medium\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;Cyclomics B.V.&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/www.cyclomics.com\/&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p>Amsterdam, The Netherlands<\/p>\n<p>AI-driven cancer diagnostics solutions. From early detection to comprehensive care.<span><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; box_shadow_style=&#8221;preset1&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663AF&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; custom_margin=&#8221;6px|||||&#8221; animation_style=&#8221;fade&#8221; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2026\/03\/Scinus_logo-300x73.jpg\" width=\"251\" height=\"61\" alt=\"\" class=\"wp-image-355 alignnone size-medium\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;Scinus Cell Expansion&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/www.scinus.com\/&#8221; url_new_window=&#8221;on&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><span>Zeist<\/span>, The Netherlands<\/p>\n<p><span><\/span><\/p>\n<p><span class=\"display-4-fs\"><span><span class=\"o_text_highlight o_translate_inline o_text_highlight_bold_1 o_text_highlight_fill\"><span class=\"h2-fs\"><span class=\"text-o-color-3\">To make cell therapies accessible for a global patient population by controlling growth with Osilaris automated scalable bioreactor for cell therapy manufacturing.\u00a0<\/span><\/span><\/span><\/span><\/span><span><\/span><\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_slider arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#FFFFFF&#8221; body_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#4663af&#8221; custom_button=&#8221;on&#8221; button_text_color=&#8221;#ffffff&#8221; button_border_color=&#8221;#ffffff&#8221; height=&#8221;400px&#8221; animation_style=&#8221;fade&#8221; hover_enabled=&#8221;0&#8243; border_color_all=&#8221;#666666&#8243; box_shadow_style=&#8221;preset1&#8243; box_shadow_blur=&#8221;20px&#8221; box_shadow_spread=&#8221;10px&#8221; global_colors_info=&#8221;{%22gcid-6564fd65-3474-4b1e-bc28-b6076e54a970%22:%91%22button_border_color%22,%22button_text_color%22%93,%22gcid-body-color%22:%91%22border_color_all%22%93}&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_slide arrows_custom_color=&#8221;gcid-967bc17b-9a1f-47cc-9524-2d499fa13663&#8243; dot_nav_custom_color=&#8221;#000000&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_enable_color=&#8221;on&#8221; global_colors_info=&#8221;{%22gcid-967bc17b-9a1f-47cc-9524-2d499fa13663%22:%91%22arrows_custom_color%22%93}&#8221; sticky_transition=&#8221;on&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/myosotisinvestments.com\/wp-content\/uploads\/2026\/04\/PamDx.png\" width=\"202\" height=\"76\" alt=\"\" class=\"wp-image-366 alignnone size-full\" \/><\/p>\n<p>[\/et_pb_slide][et_pb_slide heading=&#8221;PamDx&#8221; button_text=&#8221;Company website &#8221; button_link=&#8221;https:\/\/www.pamdx.com&#8221; arrows_custom_color=&#8221;#FFFFFF&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_transition=&#8221;on&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><span>Den Bosch, The Netherlands<\/span><\/p>\n<p><span>PamDx offers a blood-based immunotherapy guidance test, the <strong>IOpener\u00ae<\/strong>. The company\u2019s kinase-activity profiling technology and software algorithms support clinicians in their treatment decisions.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_slide][\/et_pb_slider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PortfolioAntwerpen, Belgium An innovative developer and producer of medical devices offering accurate and reliable intradermal drug delivery devices. &nbsp;\u00a0Denbighshire, United Kingdom Research and development of transplant diagnostics and immunotherapy solutions targeting\u00a0transplantation tolerance. &nbsp;\u00a0Amsterdam, The Netherlands To develop personalized therapies based on the molecular analysis of Circulating Tumor Cells. Amsterdam, The Netherlands AI-driven cancer diagnostics solutions. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-87","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/pages\/87","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/comments?post=87"}],"version-history":[{"count":35,"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/pages\/87\/revisions"}],"predecessor-version":[{"id":384,"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/pages\/87\/revisions\/384"}],"wp:attachment":[{"href":"https:\/\/myosotisinvestments.com\/index.php\/wp-json\/wp\/v2\/media?parent=87"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}